NEWS RELEASE

10/1/02

CONTACT: John Sanford, News Service: (650) 736-2151, jsanford@stanford.edu

COMMENT: Marcia Stefanick, School of Medicine: marcia.stefanick@stanford.edu

Researcher to discuss findings of estrogen, progestin trial

Dr. Marcia L. Stefanick, an associate professor (research) of medicine, is scheduled to discuss the findings of a combination hormone replacement trial that was canceled several months ago because of evidence of increased health risks.

Organized by Stanford Continuing Studies, Stefanick's talk on "The Women's Health Initiative Hormone Study: What's the Big Story?" is free and open to the public. The event will take place from 7 to 9 p.m. Tuesday, Oct. 8, in Room 40 of Jordan Hall (Building 420).

The federal study halted three years before it was supposed to end after evidence indicated that taking estrogen and progestin resulted in slight increases in breast cancer, heart attack, stroke and blood clots.

Stefanick was chair of the steering committee of the Women's Health Initiative (WHI), which directed the study.

For more information, visit http://continuingstudies.stanford.edu or call (650) 725-2650.

-30-